(At DOJ’s request Xlear joined the stipulation to dismiss.) Five big takeaways: Dismissal reinforces Xlear’s argument that the FTC lacks statutory authority to require clinical data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results